DW0929
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DW0929, covering 2016-10-10 to 2016-10-10. Get the full timeline:
Most recent: Clinical Trial Update: Phase 3 Study to Evaluate the Efficacy and Safety of the DW0929 in Patients With Primary Hypercholesterolemia [Phase 3]